Latest Goodwill Impairment News

KMD Brands reported a slight revenue increase to NZD 989 million for FY25 but faced significant underlying losses, prompting a strategic reset. The company also reinforced its commitment to tackling modern slavery risks across its global supply chain.

Myer Group posted modest sales growth in FY25, buoyed by the Apparel Brands acquisition, but faced profitability challenges from operational disruptions and macroeconomic pressures. The Group is advancing its omni-channel strategy and cost management initiatives while addressing National Distribution Centre issues.

Myer Holdings reported a 13.8% revenue increase in FY25, boosted by its acquisition of Apparel Brands, yet faced a statutory net loss of $211.2 million due to goodwill impairment. The integration of Apparel Brands is underway, with strategic growth initiatives in motion.

Rewardle Holdings clarifies its complex relationship with CloudHolter and updates on Pepper Leaf loan litigation, addressing ASX concerns over financial reporting delays.

DGL Group Limited has issued a corrected FY25 financial presentation, revealing lower EBITDA and NPAT figures due to operational challenges and restructuring costs. Despite revenue growth, the company faces a modified audit opinion on inventory and outlines strategic cost-cutting and growth investments.

Mayfield Childcare Limited reported a 14.9% revenue increase to $43.9 million for the half-year ended June 2025, but underlying earnings fell short due to occupancy struggles and underperforming acquisitions. The company faces a significant goodwill impairment and is focused on operational recovery.

Spenda Limited reported a 106% surge in revenue to $11.1 million for FY25, driven by acquisitions and expanded services, yet posted a substantial $24.3 million net loss largely due to goodwill impairment. The company’s strategic moves and funding needs highlight a pivotal phase ahead.

Althea Group Holdings reports a significant reduction in losses for FY25, driven by asset sales and strategic refocus on North American THC beverages. The company completed a $4 million capital raise and navigated leadership changes amid subsidiary liquidations.

ECS Botanics reports a 5% revenue dip to $19.5 million in FY25 but sees strong B2C growth and record harvest volumes, offset by non-cash impairments.

Bioxyne Limited reports a remarkable financial turnaround for FY2025, driven by a 217% revenue surge and its first significant profit, underpinned by expanded medicinal cannabis manufacturing and new supply contracts.

IMEXHS reported a steady first half of FY25 with revenue up 4% and annualised recurring revenue climbing 11%, driven by strong adoption of its Aquila+ radiology platform and strategic capital raising.

IMEXHS Limited reported a $3 million net loss for the half-year ending June 2025, driven by a significant goodwill impairment, while annualised recurring revenue rose 11%. The company completed a $2.6 million capital raise to support growth amid ongoing cost optimisation and automation efforts.